logo
Select company
Select metric
$ 8.43MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
64
Sector
73
Industry
75
History
60
$ 11.38Close
$ 4.26 - $ 15.16 52-Week Range
Ticker Information

Ticker

ENTA

Company Name

ENANTA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ENANTA PHARMACEUTICALS INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ENTA - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ 8.43M
3/31/2025$ -3.94M
12/31/2024$ 44.42M
9/30/2024$ -48.16M
6/30/2024$ -59.4M
3/31/2024$ -9.64M
12/31/2023$ -2.29M
9/30/2023$ 41.39M
6/30/2023$ 66.81M
3/31/2023$ 35.55M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ENANTA PHARMACEUTICALS INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 35.9M.
  • Over the past 5 years, ENANTA PHARMACEUTICALS INC's average CF - Chg. Cash has been $ -707.5K.
  • The median CF - Chg. Cash for ENANTA PHARMACEUTICALS INC during this period was $ 249K
  • ENANTA PHARMACEUTICALS INC reached its highest CF - Chg. Cash over the past 5 years at $ 66.81M.
  • The lowest CF - Chg. Cash recorded by ENANTA PHARMACEUTICALS INC in the same timeframe $ -95.25M

ENANTA PHARMACEUTICALS INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
THTX : THERATECHNOLOGIES INC $ -15.86MBDTX : BLACK DIAMOND THERAPEUTICS INC $ -2.82MPLX : PROTALIX BIOTHERAPEUTICS INC $ -5.5MALEC : ALECTOR INC $ -2.47MSGMO : SANGAMO THERAPEUTICS INC $ 12.06MCSBR : CHAMPIONS ONCOLOGY INC $ 7.43MSPRO : SPERO THERAPEUTICS INC $ -32.33MCCCC : C4 THERAPEUTICS INC $ 5.04MTRDA : ENTRADA THERAPEUTICS INC $ -112.77MCELU : CELULARITY INC $ 382K

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

ENTA - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -95.25M

Minimum

Jun 30, 2021

$ 66.81M

Maximum

Jun 30, 2023

$ -707.5K

Average

$ 249K

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.19M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.19M
median$ 116.12K
std$ 44.92M